BAILEE HANOVER: Open Payments
NPI 1518712421 · OWOSSO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,150 in 71 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $199 · 2025 $1,150
Food & beverage: $1,150
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $279 |
| Biogen, Inc. | 10 | $209 |
| Lilly USA, LLC | 8 | $170 |
| Eisai Inc. | 2 | $68 |
| UCB, Inc. | 3 | $52 |
| Amneal Pharmaceuticals LLC | 2 | $46 |
| ARGENX US, INC. | 2 | $43 |
| PFIZER INC. | 2 | $39 |
| Aucta Pharmaceuticals, Inc. | 2 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $29 |
Products named: QULIPTA, KISUNLA, TYSABRI, BOTOX, AMYVID, SKYCLARYS, CREXONT, VYVGART HYTRULO.
Industry payments across MI — which companies pay providers there.
